Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05409131 · ClinicalTrials.gov registry record · NA
Omnipod 5 System Compared to Pump Therapy
A NA study, sponsored by Insulet Corporation.
- Completed
- Registry status
- NA
- Development phase
- 196
- Enrollment target
NCT05409131: Completed NA study, sponsored by Insulet Corporation.
NCT05409131 is a NA study that has completed, run by Insulet Corporation. The registered enrollment target is 196 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (86% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05409131, a NA study, has completed, sponsored by Insulet Corporation.
- COMPLETED
- Registry status
- NA
- Development phase
- 196 participants
- Enrollment target
Study Summary
Subject will undergo a 14-day outpatient, standard therapy phase during which sensor and insulin data will be collected. This will be followed by a 90-day outpatient phase where subjects will either use the Omnipod 5 system or continue to use their personal insulin pump with the study provided continuous glucose monitoring system. Participants in France will be offered an optional extension of 12 months of Omnipod 5 System use.
Primary Outcome
Glucose metric from study continuous glucose monitoring system
Interventions
- DEVICE Omnipod 5 System
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 196 participants |
| Start Date | 2022-07-07 |
| Est. Completion | 2025-01-10 |
| Phase | NA |
What the finished NCT05409131 record still lists
NCT05409131 is an interventional study that assigns participants to a tested intervention. The registered 196 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (86% lower).
The record links to 0 conditions, and to 1 intervention - of which Omnipod 5 System is the first listed.
NCT05409131 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT05409131 about?
NCT05409131 is a clinical study titled "Omnipod 5 System Compared to Pump Therapy". Subject will undergo a 14-day outpatient, standard therapy phase during which sensor and insulin data will be collected. This will be followed by a 90-day outpatient phase where subjects will either use the Omnipod 5 system or continue to use their personal insulin pump with the study provided conti...
What is the current status of trial NCT05409131?
This trial is currently completed. It is a NA study. The enrollment target is 196 participants. The study started on 2022-07-07. Estimated completion is 2025-01-10.
What interventions are being tested in trial NCT05409131?
The interventions under investigation include: Omnipod 5 System (DEVICE).
Who is sponsoring clinical trial NCT05409131?
This trial is sponsored by Insulet Corporation, which has 16 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT05409131's enrollment target sits among peer trials
196 567th of 2000 higher than 1,434 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02822768 · 196 participants · NA
Packing Versus no Packing for Cutaneous Abscess
- NCT04250259 · 196 participants · Phase 2
SAMe Trial for Patients With Alcoholic Cirrhosis
- NCT05142592 · 196 participants · Phase 1
Phase1/2a Study for IPG7236 in Patients With Advanced Solid Tumors
- NCT05317832 · 196 participants · Phase 2
Using Smartphones to Improve Physical Activity Levels of Individuals With Spinal Cord Injury
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI